🔎 Trials Near Me

መነሻ › Multiple Myeloma › Texas › The Woodlands

በThe Woodlands፣ TX ለMultiple Myeloma የሚደረጉ ክሊኒካዊ ጥናቶች

ለMultiple Myeloma የሚደረጉ 4 ጥናቶች በThe Woodlands እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Texas Oncology - The Woodlands /ID# 278726, The Woodlands
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07095452

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Houston Methodist The Woodlands Hospital, The Woodlands
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ኦገስ 2026 · NCT06152575

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • MD Anderson in The Woodlands, Conroe · 11 ማይል ርቀት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁን 2026 · NCT05561387

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • GSK Investigational Site, Kingwood · 20 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ኤፕሪ 2026 · NCT06679101

በሌሎች ከተሞች ለMultiple Myeloma የሚደረጉ ጥናቶች

በThe Woodlands ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።